SEARCH
India Approves 2 COVID-19 Vaccines: Covaxin, Covishield Vaccines 110% सुरक्षित
LatestLY Marathi
2021-01-04
Views
2
Description
Share / Embed
Download This Video
Report
सीरम’ संस्थेने उत्पादित केलेली ‘कोव्हिशिल्ड’ आणि भारत बायोटेकची ‘कोव्हॅक्सिन’ या दोन्ही करोना लशींच्या मर्यादित आपत्कालीन वापरास भारताच्या औषध महानियंत्रकांनी रविवारी परवानगी दिली.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vclip.net//embed/x7ygpsw" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
04:09
India Approves Two COVID-19 Vaccines: Oxford-Serum Institute's Covishield & Bharat Biotech's Covaxin Receives Emergency Approval From DCGI
01:40:04
India approves Covishield, Covaxin vaccines: Road to Covid-free India?
02:20
COVID-19 Vaccine Update: Covaxin By Bharat Biotech Cleared For Phase 3 Trials By The Drugs Controller General Of India (DCGI)
01:52
Covishield, Covaxin Covid-19 vaccines to be very soon available in India: Harsh Vardhan
05:09
Covishield vs Covaxin: A comparison of the two Covid-19 vaccines approved in India
03:05
India Approves Two COVID-19 Vaccines: Covishield ও Covaxin ব্যবহারে অনুমোদন, বিরোধীদের তোপ
00:51
DCGI Gives Approval For Covaxin, Covishield Vaccines Sales In Regular Markets _ V6 News
01:08
Covid Vaccine : DCGI Approval Letter | Covaxin | Covishield | Oneindia Telugu
02:11
Covid-19 Vaccine: DCGI ने Study को दी मंजूरी, Covishield और Covaxin होंगे Mix | वनइंडिया हिंदी
07:03
Covid vaccine: DCGI approves Serum, Bharat Biotech vaccines for emergency use
02:20
COVID-19 Vaccine Update: Covaxin By Bharat Biotech Cleared For Phase 3 Trials By DCGI
01:46
COVID 19 ।Covaxin, Covishield Vaccines Likely To Cost Rs 275 After Market Nod
